Global Injectable Drug Delivery Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 22.02 Billion |
 Market Size (Forecast Year) |
USD 60.21 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球注射药物输送市场细分，按类型（注射药物输送装置、注射药物输送配方）、配方包装（安瓿、小瓶、药筒、瓶子）、治疗应用（自身免疫性疾病、激素紊乱、孤儿病、癌症、其他）、使用模式（治疗护理、免疫接种、其他）、给药部位（皮肤、循环/肌肉骨骼系统、器官、中枢神经系统）、分销渠道（医院、零售药店）、最终用户（医院和诊所、家庭护理环境、其他）– 行业趋势和预测到 2031 年。
注射药物输送市场分析
预计在预测期内，注射药物输送市场将迅速增长。由于技术的快速采用，久坐的生活方式已遍布全球。由于这种生活方式的转变，肥胖率正在上升，这导致了一系列慢性疾病，包括糖尿病和心血管疾病。随着慢性病的发展，医疗保健系统对更多关注先进药物输送技术的渴望急剧上升。因此，这导致了注射药物输送设备进入市场。
注射药物输送市场规模
2023 年全球注射药物输送市场规模价值为 220.2 亿美元，预计到 2031 年将达到 602.4 亿美元，2024 年至 2031 年预测期内的复合年增长率为 13.40%。
报告范围和市场细分
|
属性 |
注射药物输送关键市场洞察 |
|
分割 |
|
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。 |
|
主要市场参与者 |
Abbott (U.S.), B.D. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Baxter (U.S.), Gerresheimer AG (Germany), AstraZeneca (U.K.), Terumo Medical Corporation (Japan), Teva Pharmaceutical Industries Ltd.(Jerusalem), Eli Lilly and Company (U.S.), Schott AG (Germany), Sanofi (France), Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), West Pharmaceutical Services, Inc. (U.S.), SHL Medical AG (Switzerland), Insulet Corporation (U.S.), E3D Elcam Drug Delivery Devices (Israel), Ypsomed AG (Switzerland), AbbVie Inc. (U.S.), Novo Nordisk A/S (Denmark) |
Injectable Drug Delivery Market Definition
Formulations, techniques, technologies, and systems for conveying a pharmaceutical ingredient in the body are collectively referred to as drug delivery. Needle-free injectors, traditional syringes, auto injectors, and pen injectors are among the injectable drug delivery systems.
Injectable Drug Delivery Market Dynamics
Drivers
- Increasing incidences of chronic diseases will drive the market's growth rate
Due to the effective and focused drug release as well as low side-effects on the body, the global drug delivery market is primarily driven by rising prevalence of chronic diseases such as cancer around the world.
- Rising number of geriatric population will propel the growth rate of market during the forecast period
The rising geriatric population is driving the global injectable drug delivery market. The geriatric population necessitates a bigger supply of generic medications and dosages. Growing old comes with a slew of ailments, which has resulted in a spike in the medicine delivery sector.
Furthermore, the incrementing global biologics and biosimilar market will be a major factor influencing the growth of the injectable drug delivery market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the injectable drug delivery market. Also, the rise in the changing lifestyle and increasing expenditure on healthcare infrastructure are the major market drivers that will further escalate the growth of injectable drug delivery market. Other significant factors that will cushion the injectable drug delivery market's growth rate are increasing promotion of new products and new innovations.
Opportunities
- Growing number of R&D activities will boost many market opportunities during the forecast period
Moreover, the rising number of research and development activities will provide beneficial opportunities for growth in the injectable drug delivery market.Moreover, advanced prodrug implants, chip-based drug delivery, and technological advancement will provide beneficial opportunities for the market growth of the injectable drug delivery during the forecast period.
Restraints/Challenges
- Increasing contraceptive injectable preference for other mode of delivery will hamper the market's growth rate
As a result of the increased surface area available for absorption, injectable medication delivery achieves rapid systemic absorption levels. On the other hand, injectables can cause needle stick injuries and infections, as well as needle phobia, anxiety, and discomfort. To some extent, all of these issues limit the market for injectables.
- Frequent product recalls pose a major challenge for the growth of market during the forecast period
In recent years, there have been multiple product recalls in the injectable medicine delivery technology sector. Recalls can be voluntary or come from regulatory action. Injectables have also been recalled due to contamination from inorganic materials such as glass, silicone, stainless steel, and improper vial filling.
On the other hand, injuries and infections caused by needles will challenge the injectable drug delivery market. Additionally, growing use of alternative delivery methods and lack of awareness will restrain and further impede the growth rate of the market during the forecast period of 2022-2029.
This injectable drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the injectable drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Injectable Drug Delivery Market
Coronavirus is a highly contagious disease that mostly affects people's respiratory systems. The COVID-19 has afflicted people all around the world. Except for the pharmaceutical business, it had a negative impact on the running of all industries. More ventilators, testing kits, pharmaceuticals, vaccines, and oxygen cylinders are needed now than before the global pandemic. In recent years, the demand for injectable devices and other healthcare items has increased, resulting in a boom in the injectable drug delivery devices business. Every country's government is devoting a significant portion of its financial resources to acquiring and manufacturing more medicinal products and medical equipment. Vaccinations are being given to people all around the world. As a result, the market for injectable drug delivery systems is expanding.
Injectable Drug Delivery Market Scope
The injectable drug delivery market is segmented on the basis of type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Injectable Drug Delivery Devices
- Injectable Drug Delivery Formulation
On the basis of type, the injectable drug delivery market is segmented into injectable drug delivery devices and injectable drug delivery formulation. Injectable drug delivery devices have further been segmented into conventional injection devices and self-injection devices. Self-injection devices have further been sub-segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors and others. Injectable drug delivery formulation has further been segmented into conventional drug delivery formulation, novel drug delivery formulation and long-acting injection formulations. Novel drug delivery formulation has further been sub-segmented into colloidal dispersions and microparticles. Colloidal dispersions are further divided into niosomes, liposomes, polymeric/mixed micelles and nanoparticles. Micro particles are further divided into microspheres and microcapsules.
Formulation Packaging
- Ampoules
- Vials
- Cartridges
- Bottles
On the basis of formulation packaging, the injectable drug delivery market is segmented into ampoules, vials, cartridges and bottles.
Therapeutic Application
- Autoimmune Diseases
- Hormonal Disorders
- Orphan Diseases
- Cancer
- Others
Based on therapeutic application, the injectable drug delivery market is segmented into autoimmune diseases, hormonal disorders, orphan diseases, cancer and others.
Usage Pattern
- Curative Care
- Immunization
- Other
On the basis of usage pattern, the injectable drug delivery market is segmented into curative care, immunization and others.
Site of Administration
- Skin
- Circulatory/Musculoskeletal System
- Organs
- Central Nervous System
Based on site of administration, the injectable drug delivery market is segmented into skin, circulatory/musculoskeletal system, organs and central nervous system.
Distribution Channel
- Hospital
- Retail Pharmacy Stores
On the basis of distribution channel, the injectable drug delivery market is segmented into hospital and retail pharmacy stores.
End User
- Hospitals and Clinics
- Home Care Settings
- Others
The end user segment of injectable drug delivery market is segmented into hospitals and clinics, home care settings and others.
Injectable Drug Delivery Market Regional Analysis
The injectable drug delivery market is analysed and market size insights and trends are provided by country, type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel and end user as referenced above.
The countries covered in the injectable drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the injectable drug delivery market because of the increasing adoption of advanced injectable drug delivery and a large patient pool. Additionally, rising expenditure for healthcare infrastructure will flourish the market's growth rate in this region.
Asia-Pacific is expected to grow during the forecast period due to rising awareness and increasing number of patient population in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Injectable Drug Delivery Market Share Analysis
The Injectable drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to injectable drug delivery market.
Injectable Drug Delivery Market Leaders Operating in the Market Are:
- Abbott (U.S.)
- B.D. (U.S.)
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S.)
- Baxter (U.S.)
- Gerresheimer AG (Germany)
- AstraZeneca (U.K.)
- Terumo Medical Corporation (Japan)
- Teva Pharmaceutical Industries Ltd.(Jerusalem)
- Eli Lilly and Company (U.S.)
- Schott AG (Germany)
- Sanofi (France)
- Johnson & Johnson Private Limited (U.S.)
- Mylan N.V. (U.S.)
- West Pharmaceutical Services, Inc. (U.S.)
- SHL Medical AG (Switzerland)
- Insulet Corporation (U.S.)
- E3D Elcam Drug Delivery Devices (Israel)
- Ypsomed AG (Switzerland)
- AbbVie Inc. (U.S.)
- Novo Nordisk A/S (Denmark)
Latest Development in Injectable Drug Delivery
- 2022 年 1 月，West 宣布与康宁公司在制药注射药物输送领域展开里程碑式合作。作为新合作的一部分，康宁的 Valor Glass 技术将得到扩展，为制药行业提供增强型注射药物包装和输送系统，以提高患者安全性并扩大获得救命疗法的渠道。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
